Table 3.

Comparison of time-to-first infection in statin-users and non-users

Infection, mean ± SD (days)	Statin-Users (n = 12,981)	Non-Users (n = 32,266)	Adjusted HR (95% CI)
Common infections group	614 ± 409	637 ± 412	0.99 (0.95–1.02)
Influenza	745 ± 470	813 ± 463	1.10 (0.83–1.46)
Fungal infections	771 ± 434	727 ± 428	0.99 (0.93–1.05)

^*Proportional Hazards Regression; Time in days; covariates were patient age, patient gender, total Charlson Comorbidity Score, tobacco use, alcohol use/abuse, number of inpatient admissions in the baseline period, number of outpatient admissions in the baseline period, and use of the following medications: beta-blockers, diuretics, calcium-channel blockers, ACE inhibitors, oral hypoglycemics, aspirin, and steroids.